Image

Effect of Breather in COPD Patients with Intermittent Claudication

Effect of Breather in COPD Patients with Intermittent Claudication

Recruiting
50-60 years
Male
Phase N/A

Powered by AI

Overview

The aim of this study To show the effect of breather on ventilatory and vascular function in COPD patient with intermittent claudication.

Description

recent researches show that COPD patients have risk of developing peripheral arterial disease (PAD) which represented on patient by intermittent claudication inspiratory muscle trainer as the breather device show increasing in inspiratory muscle strength and endurance; reduction of dyspnea; and improving of exercise tolerance .

Because of all this things this study tends to show the effect of the breather on ventilatory and vascular function in COPD patient with intermittent claudication.

Eligibility

Inclusion Criteria:

  • sixty male patients with diagnosed with grade I and grade II COPD their ages ranged between 55-60years
  • All patients will be clinically and medically stable when attending the study.
  • Body mass index (BMI) is 18.5 to 24.9 kg/m2.
  • History of unilateral exertional leg pain,
  • Ambulation during a graded treadmill test limited by leg pain consistent with intermittent claudication (stage II of the fontaine classification of pad),
  • And an ankle-brachial index (ABI) of 0.90 or lower at rest or 0.73 or lower after exercise.

Exclusion Criteria:

  • cardiovascular insufficiency,
  • Recent myocardial infarction,
  • heart failure,
  • arrhythmia,
  • DVT,
  • Intracranial hypertension,
  • Pneumonia,
  • kidney failure,
  • fractures,
  • uncooperative patients,
  • cognitive impairment preventing a patient from participation in exercises.

Study details
    COPD
    PAD

NCT06529185

Cairo University

13 January 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.